Clinical Trial Update: Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease [NA]

View source ↗

Summary

A clinical trial is evaluating the efficacy and safety of BUFY01 versus SVS20 for dry eye disease. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• BUFY01
• SVS20

Snippet

Sponsor: TRB Chemedica International SA | Conditions: Dry Eye Disease | NA | Status: RECRUITING